Events and Presentations

DAY HI:
DAY LOW:
VOLUME:

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Events and Presentations

Presentations and Posters
Date Title Format
Jun 04, 2021
2021 ASCO Annual Meeting: CNS activity of poziotinib in NSCLC with exon 20 insertion mutations
Apr 29, 2021
Current Corporate Presentation
Apr 10, 2021
Poziotinib administered twice daily improves safety and tolerability in patients with EGFR or HER2 exon 20 mutations
Mar 05, 2021
38th Annual Miami Breast Cancer Conference: Interim safety evaluation of same-day dosing of eflapegrastim in patients with early-stage breast cancer (ESBC) receiving docetaxel and cyclophosphamide (TC)
Mar 02, 2021
ESMO TAT Virtual Congress 2021: Safety, tolerability and preliminary efficacy of poziotinib with twice daily strategy in EGFR/HER2 Exon 20 mutant non-small cell lung cancer
Upcoming Event
More events are coming soon.